Evelo Biosciences Inc (EVLO)

Currency in USD
0.02
0.00(0.00%)
Closed·
EVLO Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
Fair Value
Day's Range
0.020.02
52 wk Range
0.020.02
Key Statistics
Prev. Close
-
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.02-0.02
Volume
-
Average Volume (3m)
3.01K
1-Year Change
-50%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVLO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Evelo Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Evelo Biosciences Inc Company Profile

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Compare EVLO to Peers and Sector

Metrics to compare
EVLO
Peers
Sector
Relationship
P/E Ratio
0.0x−4.7x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x9.6x3.2x
Upside (Analyst Target)
0.0%178.3%40.5%
Fair Value Upside
Unlock6.7%4.4%Unlock

Earnings

Latest Release
Nov 09, 2023
EPS / Forecast
-0.71 / -2.80
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

EVLO Income Statement

FAQ

What Stock Exchange Does Evelo Biosciences Trade On?

Evelo Biosciences is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Evelo Biosciences?

The stock symbol for Evelo Biosciences is "EVLO."

What Is the Evelo Biosciences Market Cap?

As of today, Evelo Biosciences market cap is 379.66K.

What Is Evelo Biosciences's Earnings Per Share (TTM)?

The Evelo Biosciences EPS (TTM) is -9.65.

From a Technical Analysis Perspective, Is EVLO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Evelo Biosciences Stock Split?

Evelo Biosciences has split 1 times.

How Many Employees Does Evelo Biosciences Have?

Evelo Biosciences has 66 employees.

What is the current trading status of Evelo Biosciences (EVLO)?

As of 25 Jul 2025, Evelo Biosciences (EVLO) is trading at a price of 0.02, with a previous close of 0.00. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.02 to 0.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.